April 19 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- ENTERED WORLDWIDE EXCLUSIVE LICENSING AGREEMENT AND MASTER SERVICES AGREEMENT WITH EVOTEC SE
- WILL PAY AN IMMEDIATE UPFRONT OF A$1.6 MILLION
- AGREEMENT FOR LICENSE OF GLOBAL RIGHTS TO EVT801
- EXPECTS TO LAUNCH A PHASE I CLINICAL TRIAL IN CY2021
News: KZA Kazia Therapeutics Entered Worldwide Exclusive Licensing Deal & Master Services Deal With...
Add to My Watchlist
What is My Watchlist?